TRANSLATIONAL BIOIMAGING CORE SHARED RESOURCE (TBICSR) In vivo imaging biomarkers have become indispensable in cancer research. The Translational BioImaging Core Shared Resource (TBICSR) provides a variety of imaging resources and support for Fred Hutch/University of Washington Cancer Consortium research through the interdisciplinary operations of shared resources across institutions. The goals of TBICSR are to make the widest range of high-end imaging resources available to Consortium members in a cost effective and efficient manner. TBICSR accopmplishes this by implementing a shared use model of imaging resources (and expertise). This is the most cost-effective way to make a wide range of imaging resources available to Consortium members regardless of usage volume at an individual site. Efficiency in enacting studies is enabled by allowing skilled users to access equipment via on-line scheduling and also by providing consultation services for prospective investigators seeking advice regarding imaging options. When consultation is requested, an imaging specialist is available to assist in Institutional Animal Care and Use Committee (IACUC) writing, arrangement of inter-institutional transportation and housing if needed, and system scheduling. Optimization of imaging resources is further supported through faculty imaging modality experts that engage with investigators that desire their guidance. Imaging equipment available through TBICSR spans the range of magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT), ultrasound (US), and optical imaging. Finally, TBICSR is supported by staff with greater than 60 years of experience in conducting research imaging studies and in animal handling and management. TBICSR obtained ?Outstanding? ranking in the last CCSG cycle. The strengths of the resource were and continue to be the expertise of its imaging modality leaders and the large variety of specialized major instrumentation available to serve the imaging needs of Cancer Consortium members. In vivo imaging is an invaluable way to non-invasively and longitudinally study the disease process and therapeutic response in animals, which is so vital to Consortium research, prior to human studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853655
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Yu, Hsiang; Cheng, Yu-Jen; Wang, Ching-Yun (2018) Methods for multivariate recurrent event data with measurement error and informative censoring. Biometrics 74:966-976
Puré, Ellen; Hingorani, Sunil R (2018) Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy. Trends Cancer 4:273-277
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422
Molina, Yamile; Briant, Katherine J; Sanchez, Janeth I et al. (2018) Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn Health 23:461-479
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha et al. (2018) Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urol Oncol 36:342.e7-342.e14
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288

Showing the most recent 10 out of 1267 publications